Alisa Kirkin

Glioblastoma, the most aggressive form of brain cancer, has found a way to exploit one of the body's most fundamental processes: circadian rhythms.

A new study led by researchers from the Champalimaud Foundation in Lisbon, Portugal, has, for the first time, detected pre-cancerous lesions in the

Parts of the genome that do not code for proteins may nonetheless play a significant role in how emotional experiences can lead to drug and mental health issues, preclinical research suggests.

Larotrectinib is highly effective in children with newly diagnosed infantile fibrosarcoma or other solid tumors, according to a new study.

Researchers at the University of California, Los Angeles (UCLA) have identified a promising new blood-based biomarker that could help detect early brain changes linked to cognitive impairment and dementia.

Sangamo Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for its ST-503 program.

Researchers at the University of California (UC), San Diego, have introduced Spatial Modeling Algorithms for Reactions and Transport (SMART), an

Scientists from KU Leuven and the VIB Center for Brain and Disease Research have identified an intriguing new lead in the biology of amyotrophic

Researchers at Arizona State University (ASU) and Banner Alzheimer's Institute have uncovered an unexpected connection between cytomegalovirus (HCMV), a

New findings reveal how macrophages behave differently depending on the time of day, highlighting a potential for time-specific treatments for inflammatory diseases.